UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Total Liabilities (Quarterly): 7.156B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.156B |
| June 30, 2024 | 7.156B |
| December 31, 2023 | 7.256B |
| June 30, 2023 | 6.889B |
| June 30, 2023 | 6.889B |
| December 31, 2022 | 7.297B |
| June 30, 2022 | 7.721B |
| June 30, 2022 | 7.721B |
| December 31, 2021 | 6.594B |
| June 30, 2021 | 6.388B |
| June 30, 2021 | 6.388B |
| December 31, 2020 | 7.438B |
| June 30, 2020 | 6.893B |
| June 30, 2020 | 6.893B |
| December 31, 2019 | 4.561B |
| June 30, 2019 | 4.617B |
| June 30, 2019 | 4.617B |
| December 31, 2018 | 4.872B |
| June 30, 2018 | 4.919B |
| June 30, 2018 | 4.919B |
| December 31, 2017 | 5.016B |
| June 30, 2017 | 4.888B |
| Date | Value |
|---|---|
| June 30, 2017 | 4.888B |
| December 31, 2016 | 5.006B |
| June 30, 2016 | 5.702B |
| June 30, 2016 | 5.702B |
| December 31, 2015 | 5.915B |
| June 30, 2015 | 6.093B |
| June 30, 2015 | 6.093B |
| December 31, 2014 | 6.452B |
| June 30, 2014 | 6.913B |
| June 30, 2014 | 6.913B |
| December 31, 2013 | 7.509B |
| June 30, 2013 | 6.596B |
| June 30, 2013 | 6.596B |
| December 31, 2012 | 6.300B |
| June 30, 2012 | 5.744B |
| June 30, 2012 | 5.744B |
| December 31, 2011 | 5.796B |
| June 30, 2011 | 5.436B |
| December 31, 2010 | 5.821B |
| June 30, 2010 | 6.439B |
| December 31, 2009 | 6.725B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.561B
Minimum
Dec 2019
7.721B
Maximum
Jun 2022
6.883B
Average
6.893B
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Galapagos NV | 1.463B |
| Mithra Pharmaceuticals SA | 416.74M |
| Nyxoah SA | 42.51M |
| Celyad Oncology SA | 12.13M |
| MDxHealth SA | 140.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.75B |
| Shareholders Equity (Quarterly) | 9.597B |
| Debt to Equity Ratio | 0.3178 |
| Current Ratio | 1.187 |
| Net Debt Paydown Yield | -0.11% |